Cara Therapeutics Inc (CARA)
0.293
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 13:16
Cara Therapeutics Total Assets (Quarterly): 72.50M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 72.50M |
| March 31, 2024 | 90.10M |
| December 31, 2023 | 125.84M |
| September 30, 2023 | 115.34M |
| June 30, 2023 | 134.39M |
| March 31, 2023 | 153.28M |
| December 31, 2022 | 182.24M |
| September 30, 2022 | 213.51M |
| June 30, 2022 | 226.57M |
| March 31, 2022 | 223.87M |
| December 31, 2021 | 247.06M |
| September 30, 2021 | 225.09M |
| June 30, 2021 | 221.45M |
| March 31, 2021 | 250.23M |
| December 31, 2020 | 271.16M |
| September 30, 2020 | 147.14M |
| June 30, 2020 | 168.61M |
| March 31, 2020 | 196.17M |
| December 31, 2019 | 232.96M |
| September 30, 2019 | 263.80M |
| June 30, 2019 | 149.64M |
| March 31, 2019 | 170.59M |
| December 31, 2018 | 190.82M |
| Date | Value |
|---|---|
| September 30, 2018 | 212.70M |
| June 30, 2018 | 139.89M |
| March 31, 2018 | 80.64M |
| December 31, 2017 | 97.00M |
| September 30, 2017 | 108.05M |
| June 30, 2017 | 117.97M |
| March 31, 2017 | 43.30M |
| December 31, 2016 | 63.83M |
| September 30, 2016 | 80.15M |
| June 30, 2016 | 92.04M |
| March 31, 2016 | 102.01M |
| December 31, 2015 | 110.90M |
| September 30, 2015 | 117.90M |
| June 30, 2015 | 46.44M |
| March 31, 2015 | 51.65M |
| December 31, 2014 | 55.93M |
| September 30, 2014 | 62.37M |
| June 30, 2014 | 68.19M |
| March 31, 2014 | 71.56M |
| December 31, 2013 | 18.08M |
| September 30, 2013 | 22.07M |
| December 31, 2012 | 5.537M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
72.50M
Minimum
Jun 2024
271.16M
Maximum
Dec 2020
184.08M
Average
196.17M
Median
Mar 2020
Total Assets (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 385.92M |
| Alaunos Therapeutics Inc | 4.678M |
| Oragenics Inc | 2.710M |
| Cocrystal Pharma Inc | 21.57M |
| Citius Pharmaceuticals Inc | 97.09M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 60.90M |
| Shareholders Equity (Quarterly) | 11.60M |
| Current Ratio | 4.594 |